Invention Grant
- Patent Title: Treatment method utilizing pyrrolidine-2, 5-dione derivatives as IDO1 inhibitors
-
Application No.: US15934246Application Date: 2018-03-23
-
Publication No.: US10398679B2Publication Date: 2019-09-03
- Inventor: Stefano Crosignani , Sandra Cauwenberghs , Gregory Driessens , Frederik Deroose
- Applicant: ITEOS THERAPEUTICS
- Applicant Address: BE Charleroi
- Assignee: ITEOS THERAPEUTICS
- Current Assignee: ITEOS THERAPEUTICS
- Current Assignee Address: BE Charleroi
- Agency: Young & Thompson
- Priority: EP14168534 20140515; BE2014/0754 20141021
- Main IPC: A61K31/404
- IPC: A61K31/404 ; A61K31/4015 ; C07D207/408 ; C07D207/40 ; C07D403/04 ; C07D207/46
Abstract:
Uses of compound of Formula I: or pharmaceutically acceptable enantiomers, salts, solvates or prodrugs thereof are described. The compounds of Formula I are useful as IDO1 inhibitors. These are also useful for the treatment and/or prevention of cancer and endometriosis.
Public/Granted literature
- US20180214415A1 TREATMENT METHOD UTILIZING PYRROLIDINE-2, 5-DIONE DERIVATIVES AS IDO1 INHIBITORS Public/Granted day:2018-08-02
Information query
IPC分类:
